Review
High Impact Clinical Applications of Cardiac Magnetic Resonance Imaging in Women: A Review
Alex Diaz MD,
Chelsea Meloche MD,
Mohamed Abdelmotleb MD,
Hamid Chalian MD,
Ana Paula Santos Lima MD,
Luba Frank MD, Karen Ordovas MD, MAS,
Alex Diaz MD
University of Washington, Seattle, Washington, USA
Search for more papers by this authorChelsea Meloche MD
Texas Heart Institute at Baylor College of Medicine, Houston, Texas, USA
Search for more papers by this authorMohamed Abdelmotleb MD
University of Washington, Seattle, Washington, USA
Search for more papers by this authorHamid Chalian MD
University of Washington, Seattle, Washington, USA
Search for more papers by this authorAna Paula Santos Lima MD
University of Washington, Seattle, Washington, USA
Search for more papers by this authorCorresponding Author
Karen Ordovas MD, MAS
University of Washington, Seattle, Washington, USA
Address reprint requests to: K.O., 1959 NE Pacific Street, Seattle, WA 98195-7117, USA. E-mail: [email protected]
Search for more papers by this authorAlex Diaz MD,
Chelsea Meloche MD,
Mohamed Abdelmotleb MD,
Hamid Chalian MD,
Ana Paula Santos Lima MD,
Luba Frank MD, Karen Ordovas MD, MAS,
Alex Diaz MD
University of Washington, Seattle, Washington, USA
Search for more papers by this authorChelsea Meloche MD
Texas Heart Institute at Baylor College of Medicine, Houston, Texas, USA
Search for more papers by this authorMohamed Abdelmotleb MD
University of Washington, Seattle, Washington, USA
Search for more papers by this authorHamid Chalian MD
University of Washington, Seattle, Washington, USA
Search for more papers by this authorAna Paula Santos Lima MD
University of Washington, Seattle, Washington, USA
Search for more papers by this authorCorresponding Author
Karen Ordovas MD, MAS
University of Washington, Seattle, Washington, USA
Address reprint requests to: K.O., 1959 NE Pacific Street, Seattle, WA 98195-7117, USA. E-mail: [email protected]
Search for more papers by this authorFirst published: 13 February 2025
Abstract
The diagnosis of cardiovascular disease in women poses an ongoing challenge due to lack of knowledge about sex differences in the manifestations of cardiovascular disease, since women have been underrepresented in cardiovascular research studies that guide current practice. The purpose of this article is to review a spectrum of cardiovascular disorders which occur exclusively or more frequently in women and to highlight the role that cardiovascular magnetic resonance (MR) plays in diagnosing and prognosticating these disorders. Specifically, this review focuses on cardio-oncologic, ischemic, inflammatory, autoimmune, peri-partum, and genetic manifestations of cardiomyopathy in women. We strive to draw attention to the added diagnostic value provided by cardiac MR, compared against alternative imaging modalities, and propose opportunities for further research on sex differences in imaging and diagnosing cardiovascular diseases.
Evidence Level
1
Technical Efficacy
Stage 3
References
- 1Martin SS, Aday AW, Almarzooq ZI, et al. Heart disease and stroke statistics: A report of US and global data from the American Heart Association. Circulation 2024; 149(8): e347-e913.
- 2Melloni C, Berger JS, Wang TY, et al. Representation of women in randomized clinical trials of cardiovascular disease prevention. Circ Cardiovasc Qual Outcomes 2010; 3(2): 135-142.
- 3Dougherty AH. Gender balance in cardiovascular research: Importance to women's health. Tex Heart Inst J 2011; 38(2): 148-150.
- 4Mavrogeni S, Dimitroulas T, Gabriel S, Sfikakis PP, Pohost GM, Kitas GD. Why currently used diagnostic techniques for heart failure in rheumatoid arthritis are not enough: The challenge of cardiovascular magnetic resonance imaging. Rev Cardiovasc Med 2014; 15(4): 320-331.
- 5Grothues F, Smith GC, Moon JCC, et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol 2002; 90(1): 29-34.
- 6Ellenberger K, Jeyaprakash P, Sivapathan S, et al. The effect of obesity on echocardiographic image quality. Heart Lung Circ 2022; 31(2): 207-215.
- 7Qutbi M, Soltanshahi M. A practical method to reduce breast attenuation during SPECT myocardial perfusion imaging. J Nucl Cardiol 2018; 25(6): 2179-2181.
- 8Kramer CM, Barkhausen J, Bucciarelli-Ducci C, Flamm SD, Kim RJ, Nagel E. Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update. J Cardiovasc Magn Reson 2020; 22(1).
- 9Petersen SE, Aung N, Sanghvi MM, et al. Reference ranges for cardiac structure and function using cardiovascular magnetic resonance (CMR) in Caucasians from the UK Biobank population cohort. J Cardiovasc Magn Reson 2017; 19(1).
10.1186/s12968-017-0327-9 Google Scholar
- 10Dabir D, Child N, Kalra A, et al. Reference values for healthy human myocardium using a T1 mapping methodology: Results from the international T1 multicenter cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 2014; 16(1).
10.1186/s12968-014-0069-x Google Scholar
- 11Giaquinto AN, Sung H, Newman LA, et al. Breast cancer statistics 2024. CA Cancer J Clin 2024; 74(6): 477-495.
- 12Tamene AM, Masri C, Konety SH. Cardiovascular MR imaging in cardio-oncology. Magn Reson Imaging Clin N Am 2015; 23(1): 105-116.
- 13Jeong D, Gladish G, Chitiboi T, Fradley MG, Gage KL, Schiebler ML. MRI in cardio-oncology: A review of cardiac complications in oncologic care. J Magn Reson Imaging 2019; 50(5): 1349-1366.
- 14Kwan JM, Arbune A, Henry ML, et al. Quantitative cardiovascular magnetic resonance findings and clinical risk factors predict cardiovascular outcomes in breast cancer patients. PLoS One 2023; 18(5).
- 15Baldassarre LA, Ganatra S, Lopez-Mattei J, et al. Advances in multimodality imaging in cardio-oncology: JACC state-of-the-art review. J Am Coll Cardiol 2022; 80(16): 1560-1578.
- 16Harries I, Liang K, Williams M, et al. Magnetic resonance imaging to detect cardiovascular effects of cancer therapy: JACC CardioOncology state-of-the-art review. JACC CardioOncol 2020; 2(2): 270-292.
- 17Cardeillac M, Lefebvre F, Baicry F, et al. Symptoms of infarction in women: Is there a real difference compared to men? A systematic review of the literature with meta-analysis. J Clin Med 2022; 11(5).
- 18Hemal K, Pagidipati NJ, Coles A, et al. Sex differences in demographics, risk factors, presentation, and noninvasive testing in stable outpatients with suspected coronary artery disease: Insights from the PROMISE trial. JACC Cardiovasc Imaging 2016; 9(4): 337-346.
- 19Udell JA, Koh M, Qiu F, et al. Outcomes of women and men with acute coronary syndrome treated with and without percutaneous coronary revascularization. J Am Heart Assoc 2017; 6(1).
- 20Burgess SN, Juergens CP, Nguyen TL, et al. Comparison of late cardiac death and myocardial infarction rates in women vs men with ST-elevation myocardial infarction. Am J Cardiol 2020; 128: 120-126.
- 21D'Onofrio G, Safdar B, Lichtman JH, et al. Sex differences in reperfusion in young patients with ST-segment-elevation myocardial infarction: Results from the VIRGO study. Circulation 2015; 131(15): 1324-1332.
- 22Safdar B, Spatz ES, Dreyer RP, et al. Presentation, clinical profile, and prognosis of young patients with myocardial infarction with nonobstructive coronary arteries (MINOCA): Results from the VIRGO study. J Am Heart Assoc 2018; 7(13).
- 23Kellman P, Arai AE. Cardiac imaging techniques for physicians: Late enhancement. J Magn Reson Imaging 2012; 36(3): 529-542.
- 24Thomson LEJ, Wei J, Agarwal M, et al. Cardiac magnetic resonance myocardial perfusion reserve index is reduced in women with coronary microvascular dysfunction. Circ Cardiovasc Imaging 2015; 8(4).
- 25Gulati M, Levy PD, Mukherjee D, et al. AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guideline for the evaluation and diagnosis of CHEST pain: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2021; 144(22).
- 26Patel AR, Salerno M, Kwong RY, Singh A, Heydari B, Kramer CM. Stress cardiac magnetic resonance myocardial perfusion imaging: JACC review topic of the week. J Am Coll Cardiol 2021; 78(16): 1655-1668.
- 27Zhou W, Sin J, Yan AT, et al. Qualitative and quantitative stress perfusion cardiac magnetic resonance in clinical practice: A comprehensive review. Diagnostics Basel 2023; 13(3):524. https://doi.org/10.3390/diagnostics13030524.
- 28Greenwood JP, Maredia N, Younger JF, et al. Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): A prospective trial. Lancet 2012; 379(9814): 453-460.
- 29Laspas F, Pipikos T, Karatzis E, et al. Cardiac magnetic resonance versus single-photon emission computed tomography for detecting coronary artery disease and myocardial ischemia: Comparison with coronary angiography. Diagnostics (Basel) 2020; 10(4).
- 30Berman DS, Kang X, Slomka PJ, et al. Underestimation of extent of ischemia by gated SPECT myocardial perfusion imaging in patients with left main coronary artery disease. J Nucl Cardiol 2007; 14(4): 521-528.
- 31Emrich T, Emrich K, Abegunewardene N, et al. Cardiac MR enables diagnosis in 90% of patients with acute chest pain, elevated biomarkers and unobstructed coronary arteries. Br J Radiol 2015; 88(1049):20150025.
- 32Zeng M, Zhao C, Bao X, et al. Clinical characteristics and prognosis of MINOCA caused by atherosclerotic and nonatherosclerotic mechanisms assessed by OCT. JACC Cardiovasc Imaging 2023; 16(4): 521-532.
- 33Ciliberti G, Verdoia M, Musella F, et al. MINOCA in men and women: Different conditions and a single Destiny? Int J Cardiol 2023; 374: 6-7.
- 34Konst RE, Parker M, Bhatti L, et al. Prognostic value of cardiac magnetic resonance imaging in patients with a working diagnosis of MINOCA—An outcome study with up to 10 years of follow-up. Circ Cardiovasc Imaging 2023; 16(8).
- 35Liang K, Bisaccia G, Leo I, et al. CMR reclassifies the majority of patients with suspected MINOCA and non MINOCA. Eur Heart J Cardiovasc Imaging 2023; 25(1): 8-15.
- 36Alfonso F, Bastante T. Spontaneous coronary artery dissection in men: So rare? So different? JACC Cardiovasc Interv 2022; 15(20): 2062-2065.
- 37Saw J, Starovoytov A, Aymong E, et al. Canadian spontaneous coronary artery dissection cohort study: 3-year outcomes. J Am Coll Cardiol 2022; 80(17): 1585-1597.
- 38Lionakis N, Briasoulis A, Zouganeli V, Dimopoulos S, Kalpakos D, KoureK C. Spontaneous coronary artery dissection: A review of diagnostic methods and management strategies. World J Cardiol 2022; 14(10): 522-536.
- 39Hayes SN, Tweet MS, Adlam D, et al. Spontaneous coronary artery dissection: JACC state-of-the-art review. J Am Coll Cardiol 2020; 76(8): 961-984.
- 40Nishiguchi T, Tanaka A, Ozaki Y, et al. Prevalence of spontaneous coronary artery dissection in patients with acute coronary syndrome. Eur Heart J Acute Cardiovasc Care 2016; 5(3): 263-270.
- 41Chandrasekhar J, Thakkar J, Starovoytov A, Mayo J, Saw J. Characteristics of spontaneous coronary artery dissection on cardiac magnetic resonance imaging. Cardiovasc Diagn Ther 2020; 10(3): 636-638.
- 42Tan NY, Hayes SN, Young PM, Gulati R, Tweet MS. Usefulness of cardiac magnetic resonance imaging in patients with acute spontaneous coronary artery dissection. Am J Cardiol 2018; 122(10): 1624-1629.
- 43Kvien TK, Uhlig T, Ødegård S, Heiberg MS. Epidemiological aspects of rheumatoid arthritis: The sex ratio. Ann N Y Acad Sci 2006; 1069: 212-222.
- 44Kitas GD, Gabriel SE. Cardiovascular disease in rheumatoid arthritis: State of the art and future perspectives. Ann Rheum Dis 2011; 70(1): 8-14.
- 45Douglas KMJ, Pace AV, Treharne GJ, et al. Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary syndrome. Ann Rheum Dis 2005; 65(3): 348-353.
- 46Davis JM, Roger VL, Crowson CS, Kremers HM, Therneau TM, Gabriel SE. The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population. Arthritis Rheum 2008; 58(9): 2603-2611.
- 47Murphy G, Isenberg D. Effect of gender on clinical presentation in systemic lupus erythematosus. Rheumatology Oxford 2013; 52(12): 2108-2115. https://doi.org/10.1093/rheumatology/ket160.
- 48Urowitz MB, Bookman AA, Koehler BE, Gordon DA, Smythe HA, Ogryzlo MA. The bimodal mortality pattern of systemic lupus erythematosus. Am J Med 1976; 60(2): 221-225.
- 49Manzi S, Meilahn EN, Rairie JE, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: Comparison with the Framingham study. Am J Epidemiol 1997; 145(5): 408-415.
- 50Bartels CM, Buhr KA, Goldberg JW, et al. Mortality and cardiovascular burden of systemic lupus erythematosus in a US population-based cohort. J Rheumatol 2014; 41(4): 680-687.
- 51Ishimori ML, Martin R, Berman DS, et al. Myocardial ischemia in the absence of obstructive coronary artery disease in systemic lupus erythematosus. JACC Cardiovasc Imaging 2011; 4(1): 27-33.
- 52Varma N, Hinojar R, D'Cruz D, et al. Coronary vessel wall contrast enhancement imaging as a potential direct marker of coronary involvement: Integration of findings from CAD and SLE patients. JACC Cardiovasc Imaging 2014; 7(8): 762-770.
- 53Abdel-Aty H, Siegle N, Natusch A, et al. Myocardial tissue characterization in systemic lupus erythematosus: Value of a comprehensive cardiovascular magnetic resonance approach. Lupus 2008; 17(6): 561-567.
- 54Puntmann VO, D'Cruz D, Smith Z, et al. Native myocardial T1 mapping by cardiovascular magnetic resonance imaging in subclinical cardiomyopathy in patients with systemic lupus erythematosus. Circ Cardiovasc Imaging 2013; 6(2): 295-301.
- 55Peoples C, Thomas AM Jr, Lucas M, Rosario BL, Feghali-Bostwick CA. Gender differences in systemic sclerosis: Relationship to clinical features, serologic status and outcomes. J Scleroderma Relat Disord 2016; 1(2): 177-240.
- 56Ntusi NA, Piechnik SK, Francis JM, et al. Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis--a clinical study using myocardial T1-mapping and extracellular volume quantification. J Cardiovasc Magn Reson 2014; 16(1).
10.1186/1532-429X-16-21 Google Scholar
- 57Champion HC. The heart in scleroderma. Rheum Dis Clin North Am 2008; 34(1): 181-188.
- 58Clements PJ, Lachenbruch PA, Furst DE, Paulus HE, Sterz MG. Cardiac score. A semiquantitative measure of cardiac involvement that improves prediction of prognosis in systemic sclerosis. Arthritis Rheum 1991; 34(11): 1371-1380.
- 59Hachulla AL, Launay D, Gaxotte V, et al. Cardiac magnetic resonance imaging in systemic sclerosis: A cross-sectional observational study of 52 patients. Ann Rheum Dis 2009; 68(12): 1878-1884.
- 60Lindholm A, Hesselstrand R, Rådegran G, Arheden H, Ostenfeld E. Decreased biventricular longitudinal strain in patients with systemic sclerosis is mainly caused by pulmonary hypertension and not by systemic sclerosis per se. Clin Physiol Funct Imaging 2019; 39(3): 215-225.
- 61Kobayashi H, Yokoe I, Hirano M, et al. Cardiac magnetic resonance imaging with pharmacological stress perfusion and delayed enhancement in asymptomatic patients with systemic sclerosis. J Rheumatol 2009; 36(1): 106-112.
- 62Verhaert D, Richards K, Rafael-Fortney JA, Raman SV. Cardiac involvement in patients with muscular dystrophies. Circ Cardiovasc Imaging 2011; 4(1).
- 63A F, S R, M B, et al. Cardiac involvement in female Duchenne and Becker muscular dystrophy carriers in comparison to their first-degree male relatives: A comparative cardiovascular magnetic resonance study. Eur Heart J Cardiovasc Imaging 2016; 17(3): 326-333.
- 64Wang RY, Lelis A, Mirocha J, Wilcox WR. Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life. Genet Med 2007; 9(1): 34-45.
- 65Wilcox WR, Oliveira JP, Hopkin RJ, et al. Females with Fabry disease frequently have major organ involvement: Lessons from the Fabry Registry. Mol Genet Metab 2008; 93(2): 112-128.
- 66Nordin S, Kozor R, Baig S, et al. Cardiac phenotype of Prehypertrophic Fabry disease. Circ Cardiovasc Imaging 2018; 11(6).
- 67Pica S, Sado DM, Maestrini V, et al. Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2014; 16(1).
- 68Vijapurapu R, Nordin S, Baig S, et al. Global longitudinal strain, myocardial storage and hypertrophy in Fabry disease. Heart 2019; 105(6): 470-476.
- 69Roy A, Umar H, Ochoa-Ferraro A, et al. Atherosclerosis in Fabry disease—A contemporary review. J Clin Med 2021; 10(19).
- 70Petryka-Mazurkiewicz J, Kryczka K, Mazurkiewicz Ł, et al. Cardiovascular magnetic resonance in peripartum cardiomyopathy: Comparison with idiopathic dilated cardiomyopathy. Diagnostics 2021; 11(10): 1752.
- 71Tidswell M. Peripartum cardiomyopathy. Crit Care Clin 2004; 20(4): 777-788.
- 72Davis MB, Arany Z, McNamara DM, Goland S, Elkayam U. Peripartum cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardiol 2020; 75(2): 207-221.
- 73Arora NP, Mohamad T, Mahajan N, et al. Cardiac magnetic resonance imaging in peripartum cardiomyopathy. Am J Med Sci 2014; 347(2): 112-117.
- 74Haghikia A, Röntgen P, Vogel-Claussen J, et al. Prognostic implication of right ventricular involvement in peripartum cardiomyopathy: A cardiovascular magnetic resonance study. ESC Heart Fail 2015; 2(4): 139-149.
- 75Kotecha T, Chacko L, Chehab O, et al. Assessment of multivessel coronary artery disease using cardiovascular magnetic resonance pixelwise quantitative perfusion mapping. J Am Coll Cardiol Img 2020; 13(12): 2546-2557.
10.1016/j.jcmg.2020.06.041 Google Scholar
- 76Christodoulou AG, Cruz G, Arami A, et al. The future of cardiovascular magnetic resonance: All-in-one vs. real-time (part 1). J Cardiovasc Magn Reson 2024; 26(1).
- 77Raman SV, Markl M, Patel AR, et al. 30-minute CMR for common clinical indications: A Society for Cardiovascular Magnetic Resonance white paper. J Cardiovasc Magn Reson 2022; 24(1).
